211
Views
14
CrossRef citations to date
0
Altmetric
Research Article

The effects of nodakenin on airway inflammation, hyper-responsiveness and remodeling in a murine model of allergic asthma

, , , , &
Pages 341-348 | Received 27 May 2014, Accepted 17 Jul 2014, Published online: 04 Aug 2014

References

  • Stocks J, Sonnappa S. Early life influences on the development of chronic obstructive pulmonary disease. Ther Adv Respir Dis 2013;7:161–173
  • Sears MR. Predicting new and persistent asthma. Am J Respir Crit Care Med 2012;186:469–470
  • Manise M, Holtappels G, Van Crombruggen K, et al. Sputum IgE and cytokines in asthma: relationship with sputum cellular profile. PLoS One 2013;8:e58388. doi: 10.1371/journal.pone.0058388
  • Lambrecht BN, Hammad H. The airway epithelium in asthma. Nat Med 2012;18:684–692
  • Schroeder BW, Verhaeghe C, Park SW, et al. AGR2 is induced in asthma and promotes allergen-induced mucin overproduction. Am J Respir Cell Mol Biol 2012;47:178–185
  • Soltani A, Muller HK, Sohal SS, et al. Distinctive characteristics of bronchial reticular basement membrane and vessel remodelling in chronic obstructive pulmonary disease (COPD) and in asthma: they are not the same disease. Histopathology 2012;60:964–970
  • Berair R, Saunders R, Brightling CE. Origins of increased airway smooth muscle mass in asthma. BMC Med 2013;11:145–152
  • Hoshino M, Nakamura Y, Sim J, et al. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J Allergy Clin Immunol 1998;102:783–788
  • Ward C, Pais M, Bish R, et al. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 2002;57:309–316
  • Cates CJ, Jaeschke R, Schmidt S, Ferrer M. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events. Cochrane Database Syst Rev 2013;3:CD006922. doi: 10.1002/14651858.CD006922.pub3. PMID: 23543548
  • Meng X, Jia M, Zhang Y, et al. Pharmacological studies of variet of Qian-hu. Pharmacol Clin Chinese Mater Med 1997;13:35–38
  • Yao NH, Kong LY. Chemical constituents of Peucedanum decursivum. Yao Xue Xue Bao 2001;36:351–355
  • Rim HK, Cho W, Sung SH, Lee KT. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock. J Pharmacol Exp Ther 2012;342:654–664
  • Joo SS, Park D, Shin S, et al. Anti-allergic effects and mechanisms of action of the ethanolic extract of Angelica gigas in dinitrofluorobenzene-induced inflammation models. Environ Toxicol Pharmacol 2010;30:127–133
  • Kang SY, Kim YC. Neuroprotective coumarins from the root of Angelica gigas: structure-activity relationships. Arch Pharm Res 2007;30:1368–1373
  • McMillan SJ, Kearley J, Campbell JD, et al. Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation. J Immunol 2004;172:2586–2594
  • Xiong Y, Wang J, Wu F, et al. Effects of (±)-praeruptorin A on airway inflammation, airway hyperresponsiveness and NF-κB signaling pathway in a mouse model of allergic airway disease. Eur J Pharmacol 2012;683:316–324
  • Scanlon ST, McKenzie AN. Type 2 innate lymphoid cells: new players in asthma and allergy. Curr Opin Immunol 2012;24:707–712
  • Robinson DS. Th-2 cytokines in allergic disease. Br Med Bull 2000;56:956–968
  • Walter DM, McIntire JJ, Berry G, et al. Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J Immunol 2001;167:4668–4675
  • Palmqvist C, Wardlaw AJ, Bradding P. Chemokines and their receptors as potential targets for the treatment of asthma. Br J Pharmacol 2007;151:725–736
  • Kasaian MT, Marquette K, Fish S, et al. An IL-4/IL-13 dual antagonist reduces lung inflammation, airway hyperresponsiveness, and IgE production in mice. Am J Respir Cell Mol Biol 2013;49:37–46
  • Yamaguchi Y, Suda T, Suda J, et al. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med 1988;167:43–56
  • Gueders MM, Foidart JM, Noe A, Cataldo DD. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. Eur J Pharmacol 2006;533:133–144
  • Cataldo DD, Gueders M, Munaut C, et al. Matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) mRNA transcripts in the bronchial secretions of asthmatics. Lab Invest 2004;84:418–424
  • Cataldo D, Munaut C, Noël A, et al. MMP-2 and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol 2000;123:259–267
  • Coraux C, Roux J, Jolly T, Birembaut P. Epithelial cell-extracellular matrix interactions and stem cells in airway epithelial regeneration. Proc Am Thorac Soc 2008;5:689–694
  • Vieillard-Baron A, Frisdal E, Eddahibi S, et al. Inhibition of matrix metalloproteinases by lung TIMP-1 gene transfer or doxycycline aggravates pulmonary hypertension in rats. Circ Res 2000;87:418–425
  • Jung YW, Zindl CL, Lai JF, et al. MMP induced by Gr-1 + cells are crucial for recruitment of Th cells into the airways. Eur J Immunol 2009;39:2281–2292
  • Kim DY, Ryu SY, Lim JE, et al. Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model. Eur J Pharmacol 2006;557:76–86
  • Pouliot P, Olivier M. Opposing forces in asthma: regulation of signaling pathways by kinases and phosphatases. Crit Rev Immunol 2009;29:419–442
  • Roth M, Black JL. Transcription factors in asthma: are transcription factors a new target for asthma therapy? Curr Drug Targets 2006;7:589–595
  • Kang SY, Lee KY, Sung SH, et al. Coumarins isolated from angelica gigas inhibit acetylcholinesterase: structure−activity relationships. J Nat Prod 2001;64:683–685
  • Degano B, Prévost MC, Berger P, et al. Estradiol decreases the acetylcholine-elicited airway reactivity in ovariectomized rats through an increase in epithelial acetylcholinesterase activity. Am J Respir Crit Care Med 2001;164:1849–1854

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.